Home
The Founder
FilleRx Technology
USA Contact
FilleRx Videos
Revolutionary Tech.
Error Free Pharma
Packaging & Inspection
Vision & NIR Tech.
Limitations
Naive Use of Camera
Poor Remedy
 Fire to Frying Pan
Vision & NIR
FilleRx Technology
FilleRx Main Functions
Non-Stop Filling
Audit Trails
Production Rate
Cluster of Cameras
Money Back Guarantee
Neural Network
Cohesive Technology
Ease of Operation
New Products
Cost Advantage
Prior to Packaging
Mathematical Weighing
Preventing Recalls
The SpectRx™ NIR
Incorporating Tech.
Market & Customer
Traditional Filling
Product Assurance
Market Potential
Searle-Pfizer FilleRx®
Applications
Technologies
Services
News
Contact
Applications
Awards & Achievements
Sales & Marketing
Press Release
Jobs
Offers
Map
This week's special offer
 



TECHNOLOGIES

             To ensure and guarantee complete product integrity with superior packaging performance, both qualitatively and quantitatively, American SensoRx, Inc., incorporated its two proprietary technologies in the FilleRx® pharmaceutical packaging system. The two proprietary technologies are the InspectRx® advanced vision system, and the SpectRx™ Near Infrared system. 

 

              The SpectRx™ NIR system has been used extensively for the Cordis Stent, a Johnson and Johnson product, where it analyzed 4 proprietary polymers and a drug layer by weight deposited on the Stent mesh surface.  Ortho McNeil, Johnson & Johnson was the first company to use the SpectRx™ system for tablet evaluation and measure the hardness and disintegration in 1994.  In addition, they have used the SpectRx™ system to assess and evaluate Ortho McNeil tablet compositions, which were made partly in Japan and in the USA.


Top